These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

831 related items for PubMed ID: 106067

  • 1. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
    Smith R, Donald RA, Espiner EA, Stronach SG, Edwards IA.
    J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
    [Abstract] [Full Text] [Related]

  • 2. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W, Solbach HG, Kley HK, Nieschlag E, Rudorff KH, Krüskemper HL.
    Horm Res; 1976 Jan; 7(1):1-10. PubMed ID: 793974
    [Abstract] [Full Text] [Related]

  • 3. The effects of prolonged administration of D-Ser (TBU)6-LH-RH-EA10 (HOE 766) in subjects with hypogonadotrophic hypogonadism.
    Smith R, Donald RA, Espiner EA, Stronach S.
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):553-9. PubMed ID: 391447
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of hypogonadotropic hypogonadal male patients with the luteinizing hormone-relasing hormone (LH-RH) anolog D-Ser(TBU)6 EA10 LH-RH: transient disappearance of gonadotropin stimulation.
    Morel Y, Fournier M, Mazenod B, Tourniaire J, Mornex R.
    Fertil Steril; 1982 Jul; 38(1):85-91. PubMed ID: 6807722
    [Abstract] [Full Text] [Related]

  • 5. The effects of different dose regimes of D-SER(TBU)6-LHRH-EA10 (HOE 766) in subjects with hypogonadotrophic hypogonadism.
    Moore MP, Smith R, Donald RA, Espiner EA, Stronach S.
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):93-7. PubMed ID: 6784983
    [Abstract] [Full Text] [Related]

  • 6. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
    Finkelstein JS, Spratt DI, O'Dea LS, Whitcomb RW, Klibanski A, Schoenfeld DA, Crowley WF.
    J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
    [Abstract] [Full Text] [Related]

  • 7. Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells.
    Finkelstein JS, Badger TM, O'Dea LS, Spratt DI, Crowley WF.
    J Clin Invest; 1988 Jun; 81(6):1725-33. PubMed ID: 3290251
    [Abstract] [Full Text] [Related]

  • 8. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C, Tso SC, Todd D.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ, Hermanussen M, Sippell WG.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [Abstract] [Full Text] [Related]

  • 10. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH, Fleischer N, Lev-Gur M, Freeman RG.
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [Abstract] [Full Text] [Related]

  • 11. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
    Szilágyi G, Szabolcs I, Vydra G, Góth M, Irsy G.
    Acta Med Hung; 1984 Dec; 41(4):175-83. PubMed ID: 6440114
    [Abstract] [Full Text] [Related]

  • 12. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 13. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
    Lachelin GC, Yen SS.
    J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
    [Abstract] [Full Text] [Related]

  • 14. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL, Wang CF, Yen SS.
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ovulation inhibition by daily i.m. administration of a highly active LH-RH analog (d-ser(TBU)6-LH-RH-(1-9)-nonapeptide-ethylamide).
    Baumann R, Kuhl H, Taubert HD, Sandow J.
    Contraception; 1980 Feb; 21(2):191-7. PubMed ID: 6768492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.